GB0116385D0 - Mycobacterial antigens expressed during latency - Google Patents

Mycobacterial antigens expressed during latency

Info

Publication number
GB0116385D0
GB0116385D0 GB0116385A GB0116385A GB0116385D0 GB 0116385 D0 GB0116385 D0 GB 0116385D0 GB 0116385 A GB0116385 A GB 0116385A GB 0116385 A GB0116385 A GB 0116385A GB 0116385 D0 GB0116385 D0 GB 0116385D0
Authority
GB
United Kingdom
Prior art keywords
expressed during
antigens expressed
mycobacterial antigens
during latency
latency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0116385A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Original Assignee
Microbiological Research Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Research Authority filed Critical Microbiological Research Authority
Priority to GB0116385A priority Critical patent/GB0116385D0/en
Publication of GB0116385D0 publication Critical patent/GB0116385D0/en
Priority to AU2002314358A priority patent/AU2002314358C1/en
Priority to EP02740929A priority patent/EP1404706A2/en
Priority to PCT/GB2002/003052 priority patent/WO2003004520A2/en
Priority to CA2453173A priority patent/CA2453173C/en
Priority to EP10150877A priority patent/EP2196473A1/en
Priority to JP2003510686A priority patent/JP2005508613A/en
Priority to US10/482,706 priority patent/US7393540B2/en
Priority to US12/140,163 priority patent/US8003776B2/en
Priority to AU2008243118A priority patent/AU2008243118A1/en
Priority to US13/214,776 priority patent/US8399650B2/en
Ceased legal-status Critical Current

Links

GB0116385A 2001-07-04 2001-07-04 Mycobacterial antigens expressed during latency Ceased GB0116385D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0116385A GB0116385D0 (en) 2001-07-04 2001-07-04 Mycobacterial antigens expressed during latency
US10/482,706 US7393540B2 (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
CA2453173A CA2453173C (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
EP02740929A EP1404706A2 (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
PCT/GB2002/003052 WO2003004520A2 (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
AU2002314358A AU2002314358C1 (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
EP10150877A EP2196473A1 (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during latency
JP2003510686A JP2005508613A (en) 2001-07-04 2002-07-04 Mycobacterial antigens expressed during incubation
US12/140,163 US8003776B2 (en) 2001-07-04 2008-06-16 Mycobacterial antigens expressed during latency
AU2008243118A AU2008243118A1 (en) 2001-07-04 2008-11-05 Mycobacterial antigens expressed during latency
US13/214,776 US8399650B2 (en) 2001-07-04 2011-08-22 Mycobacterial antigens expressed during latency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0116385A GB0116385D0 (en) 2001-07-04 2001-07-04 Mycobacterial antigens expressed during latency

Publications (1)

Publication Number Publication Date
GB0116385D0 true GB0116385D0 (en) 2001-08-29

Family

ID=9917943

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0116385A Ceased GB0116385D0 (en) 2001-07-04 2001-07-04 Mycobacterial antigens expressed during latency

Country Status (1)

Country Link
GB (1) GB0116385D0 (en)

Similar Documents

Publication Publication Date Title
AU2002351623A8 (en) Streptococcus antigens
EP1432444A4 (en) Anti-a-beta antibodies
HK1074206A1 (en) Anti-trail-r antibodies
HUP0402259A3 (en) Vaccines
HUP0402471A3 (en) Vaccine
GB0407935D0 (en) Vaccine
IL157498A0 (en) Vaccine
EP1423141A4 (en) Vaccine
AU2002365649A8 (en) Anti-dota antibody
GB0126378D0 (en) Antigen
GB0121171D0 (en) Vaccine
EP1462456A4 (en) Tumor antigens
EP1390387A4 (en) Cancer-testis antigens
EP1399478A4 (en) Cancer-testis antigens
GB0125535D0 (en) Mycobacterial genes down-regulated during latency
GB0123993D0 (en) Mycobacterial antigens expressed during latency
GB0116385D0 (en) Mycobacterial antigens expressed during latency
GB0105238D0 (en) Vaccines
AU2002303093A1 (en) Mycobacterial vaccines
GB0125659D0 (en) Spermicides
GB0111492D0 (en) Antigens
GB0119479D0 (en) Antigens
GB0112448D0 (en) Antigens
GB0126522D0 (en) Antigen
AU2535P (en) PP300 Poa poiformis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
COOA Change in applicant's name or ownership of the application

Owner name: HEALTH PROTECTION AGENCY

Free format text: FORMER APPLICANT(S): MICROBIOLOGICAL RESEARCH AUTHORITY